Short answer
CONMED Corp (CNMD) filed its Q2 2026 10-Q quarterly report on Jul 29, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $661M (up 92.9% year over year) with net income of $37M.
Q2 2026 key financials · XBRL
- Revenue
- $661M
- +92.9% YoY
- Net income
- $37M
- +72.3% YoY
- Operating margin
- 9.4%
- Gross margin
- 57.7%
- EPS (diluted)
- $1.22
- +76.8% YoY
Source: XBRL data from the CONMED Corp (CNMD) Q2 2026 10-Q on SEC EDGAR. USD.
CONMED Corp Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $343.5M, up 0.3% YoY from $342.3M
- Operating margin 10.6% vs 11.1% YoY; gross margin 57.5% vs 55.0%
- Orthopedic surgery best performer: $152.3M, up 8.2%; general surgery worst: $191.2M, down 5.2%
- Operating cash flow $50.6M vs $70.7M YoY; capital expenditures $5.8M vs $9.5M
- $637.2M spent repurchasing notes; $43.2M spent on common-stock repurchases
- Headwinds: inflation, supply-chain challenges, tariffs, and potential need for further cost reductions or debt refinancing
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CONMED Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.